M (n = 109) | P (n = 109) | p-value | |
---|---|---|---|
Age (years) | |||
Under 60 | 16 (15%) | 22 (20%) | 0.4125 |
60–69 | 21 (19%) | 26 (24%) | |
70–79 | 43 (39%) | 40 (37%) | |
Over 80 | 29 (27%) | 21 (19%) | |
Sex (men), n (%) | 67 (61.5%) | 75 (68.8%) | 0.2555 |
Body mass index (kg/m2) | 23.1 ± 3.6 | 22.9 ± 3.7 | 0.6833 |
Hypertension, n (%) | 80 (73.4%) | 71 (65.1) | 0.1865 |
Dyslipidemia, n (%) | 53 (48.6%) | 46 (42.2%) | 0.3410 |
DM, n (%) | 29 (26.6%) | 20 (18.3%) | 0.1442 |
Smoking history, n (%) | 59 (54.1%) | 59 (54.1%) | 1.0000 |
HD, n (%) | 2 (1.8%) | 6 (5.5%) | 0.1496 |
History of stroke, n (%) | 9 (8.3%) | 10 (9.2%) | 0.8102 |
Orthopedic disease, n (%) | 22 (20.2%) | 16 (14.7%) | 0.2841 |
Hb (g/dL) | 12.7 ± 2.0 | 13.0 ± 1.9 | 0.1888 |
Platelet (x103/µL) | 20.7 ± 6.5 | 20.3 ± 5.6 | 0.6192 |
Alb (g/dL) | 3.9 ± 0.5 | 4.0 ± 0.5 | 0.2320 |
eGFR (mL/min/1.73 m2) | 57.9 ± 19.5 | 60.7 ± 22.6 | 0.3376 |
BNP (pg/mL) | 238.4 ± 553.1 | 246.7 ± 491.4 | 0.9136 |
PT (sec) | 13.1 ± 2.2 | 12.9 ± 2.5 | 0.5298 |
PT-INR | 1.22 ± 0.30 | 1.30 ± 0.46 | 0.1137 |
APTT (sec) | 34.8 ± 9.0 | 34.1 ± 6.1 | 0.4794 |
HbA1c (%) | 6.0 ± 1.0 | 5.9 ± 0.7 | 0.4071 |
Ejection fraction (%) | 63.2 ± 12.7 | 62.3 ± 14.4 | 0.6304 |
Preoperative drugs | |||
Aspirin | 23 (21.1%) | 27 (24.7%) | 0.5191 |
Clopidogrel | 10 (9.2%) | 11 (10.1%) | 0.8184 |
Warfarin | 3 (2.8%) | 6 (5.5%) | 0.3071 |
NOAC | 17 (15.6%) | 13 (11.9%) | 0.4316 |
Diagnosis | |||
Ischemic | 21 (19%) | 25 (23%) | 0.8254 |
Aortic Stenosis | 21 (19%) | 17 (15%) | |
Aortic Regurgitation | 11 (10%) | 12 (11%) | |
Mitral Stenosis | 1 (1%) | 3 (3%) | |
Mitral Regurgitation | 23 (21%) | 22 (20%) | |
Aneurysm | 19 (18%) | 14 (13%) | |
Dissection | 10 (9%) | 10 (9%) | |
Others | 3 (3%) | 6 (6%) | |
Pre-operative SPPB | 11.3 ± 1.4 | 11.3 ± 1.3 | 0.8575 |
Euro Score (%) | 6.7 ± 9.7 | 5.7 ± 6.8 | 0.3904 |